https://www.businesswire.com/news/h...reMost-Completes-15M-£11M-Series-A-Enter-Drug
They can raise this with a supposedly antiquated version of our library if I understand some previous posts correctly that Phoremost was born out of PYC tech. Might be able to find out what this values Phoremost at by PYC annual report showing the diluted shareholding.
Also interesting -
https://www.fiercebiotech.com/biote...diting-crispr-startup-officially-launches-87m
In the CRISPR space.
Can’t help but think someone is going to come knocking for the whole library if PYC stays at this level compared to an implied valuation based on those capital raises. Acquirers knocking and Tribe blocking? Mind you the other ASX biotechs I watch seem undervalued to so maybe the ASX is just a failed space in biotech.
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.030(2.35%) |
Mkt cap ! $729.0M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.25 | $63.95K | 51.08K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 18084 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 5800 | 2 |
View Market Depth
| Last trade - 11.24am 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |